Global Celecoxib Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Celecoxib market size will reach 1,676.36 Million USD in 2025 and is projected to reach 3,009.77 Million USD by 2032, with a CAGR of 8.72% (2025-2032). Notably, the China Celecoxib market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Celecoxib is a medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is commonly prescribed for the management of pain, inflammation, and swelling associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Celecoxib works by inhibiting the production of specific chemicals called prostaglandins, which are responsible for inflammation and pain. Unlike traditional NSAIDs, celecoxib selectively targets the COX-2 enzyme, reducing the risk of stomach ulcers and gastrointestinal side effects. It is available in oral capsule form and is typically taken once or twice a day. However, like all medications, celecoxib may carry certain risks and side effects, so it is essential to use it under the guidance of a healthcare professional and follow the prescribed dosage and duration of treatment.
The major global suppliers of Celecoxib include Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Celecoxib. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Celecoxib market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Celecoxib market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Celecoxib industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Celecoxib Include:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Celecoxib Product Segment Include:
50mg
100mg
200mg
400mg
Celecoxib Product Application Include:
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Celecoxib Industry PESTEL Analysis
Chapter 3: Global Celecoxib Industry Porter's Five Forces Analysis
Chapter 4: Global Celecoxib Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Celecoxib Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Celecoxib Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Celecoxib Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Celecoxib market size will reach 1,676.36 Million USD in 2025 and is projected to reach 3,009.77 Million USD by 2032, with a CAGR of 8.72% (2025-2032). Notably, the China Celecoxib market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Celecoxib is a medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is commonly prescribed for the management of pain, inflammation, and swelling associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Celecoxib works by inhibiting the production of specific chemicals called prostaglandins, which are responsible for inflammation and pain. Unlike traditional NSAIDs, celecoxib selectively targets the COX-2 enzyme, reducing the risk of stomach ulcers and gastrointestinal side effects. It is available in oral capsule form and is typically taken once or twice a day. However, like all medications, celecoxib may carry certain risks and side effects, so it is essential to use it under the guidance of a healthcare professional and follow the prescribed dosage and duration of treatment.
The major global suppliers of Celecoxib include Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Celecoxib. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Celecoxib market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Celecoxib market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Celecoxib industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Celecoxib Include:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Celecoxib Product Segment Include:
50mg
100mg
200mg
400mg
Celecoxib Product Application Include:
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Celecoxib Industry PESTEL Analysis
Chapter 3: Global Celecoxib Industry Porter's Five Forces Analysis
Chapter 4: Global Celecoxib Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Celecoxib Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Celecoxib Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Celecoxib Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Celecoxib Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Celecoxib Product by Type
- 1.2.1 50mg
- 1.2.2 100mg
- 1.2.3 200mg
- 1.2.4 400mg
- 1.3 Celecoxib Product by Application
- 1.3.1 Rheumatoid arthritis
- 1.3.2 osteoarthritis
- 1.3.3 Acute pain
- 1.3.4 Musculoskeletal pain
- 1.3.5 Other
- 1.4 Global Celecoxib Market Size Analysis (2020-2032)
- 1.5 Celecoxib Market Development Status and Trends
- 1.5.1 Celecoxib Industry Development Status Analysis
- 1.5.2 Celecoxib Industry Development Trends Analysis
- 2 Celecoxib Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Celecoxib Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Celecoxib Market Analysis by Country
- 4.1 Global Celecoxib Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Celecoxib Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Celecoxib Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.5 China Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.6 France Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.14 India Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Celecoxib Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Celecoxib Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Celecoxib Market Revenue by Key Suppliers (2021-2025)
- 5.2 Celecoxib Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Celecoxib Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Celecoxib Market Analysis by Type
- 6.1 Global Celecoxib Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Celecoxib Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pfizer Inc
- 7.1.1 Pfizer Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pfizer Inc Celecoxib Product Portfolio
- 7.1.3 Pfizer Inc Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Teva
- 7.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Teva Celecoxib Product Portfolio
- 7.2.3 Teva Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Mylan
- 7.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Mylan Celecoxib Product Portfolio
- 7.3.3 Mylan Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Apotex
- 7.4.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Apotex Celecoxib Product Portfolio
- 7.4.3 Apotex Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Lupin
- 7.5.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Lupin Celecoxib Product Portfolio
- 7.5.3 Lupin Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Hengrui Medicine
- 7.6.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hengrui Medicine Celecoxib Product Portfolio
- 7.6.3 Hengrui Medicine Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Celecoxib Industry Chain Analysis
- 8.2 Celecoxib Product Downstream Application Analysis
- 8.2.1 Global Celecoxib Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Celecoxib Revenue and Forecast by Application (2020-2032)
- 8.3 Celecoxib Typical Downstream Customers
- 8.4 Celecoxib Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
